Jonsson-Oldenbuettel, Celia; Ghosn, Jade; van-der-Valk, Marc; Florence, Eric; Vera, Francisco; De-Wit, Stephane; Rami, Agathe; Bonnet, Fabrice; Hocqueloux, Laurent; Hove, Kai; Ait-Khaled, Mounir; DeMoor, Rebecca; Bontempo, Gilda; Latham, Christine-L; Gutner, Cassidy-A; Iyer, Supriya; Gill, Martín; Czarnogorski, Maggie; D'Amico, Ronald; van-Wyk, Jean
(LIPPINCOTT WILLIAMS & WILKINS, 2024-08-15)
BACKGROUND: Cabotegravir + rilpivirine long-acting (CAB + RPV LA) dosed every 2 months (Q2M) is a complete regimen for the maintenance of HIV-1 virologic suppression. In this study, we report month 12 clinical outcomes in ...